Affimed N.V. Stock News

Affimed N.V. (AFMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revis

Affimed N.V. (AFMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday The Dow traded up 0.80% to 33,745.43 while the NASDAQ rose 0.42% to 11,050.89. The S&P 500 als

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share

H.C. Wainwright initiated coverage on Affimed NV (NASDAQ: AFMD), a clinical-stage biotechnology company focused on developing innate cell engagers (ICEs) for cancer treatment.  The analyst has a B

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday The Dow traded up 0.84% to 33,757.34 while the NASDAQ rose 0.37% to 11,045.45. The S&P 500 also r

U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session. Affimed N.V.. (NASDAQ: AFMD) shares dipped 39.2%

Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers Intl Gr earned $1.41 in the third quarter, compared to $1.27 in the

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Monday Following the market opening Monday, the Dow traded up 0.35% to 33,592.23 while the NASDAQ rose 0.01% to 11

Affimed (NASDAQ:AFMD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 1 0 0 Last 30D 1 2

Analysts have provided the following ratings for Affimed (NASDAQ:AFMD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 1 0 0 Last 30

HEIDELBERG, Germany, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back t

HEIDELBERG, Germany, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back t

HEIDELBERG, Germany,, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE: ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company ag